MedPath

Comparative evaluation of efficacy of triphala, chlorhexidine and betadine mouthwash as a preprocedural rinse in reducing microbial count in dental aerosol: a randomized clinical trial.

Phase 3
Registration Number
CTRI/2022/05/042601
Lead Sponsor
DR SNEHAL VILAS THAMKE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Individuals who give consent to participate.

2.Participants having minimum of 20 permanent teeth.

3.Patient having dental problem and who need restoration and endodontic treatment

Exclusion Criteria

1.Subjects suffering from any systemic diseases

2.Received antibiotics or nonsteroidal anti-inflammatory drugs in past 1- 3 months

3.Oral prophylaxis within the past three month

4.Participant using other mouthwash

5.Pregnant and lactating mothers

6.Use of smoke and smokeless tobacco products

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
There is a difference in the efficacy of Triphala, Chlorhexidine and Betadine mouthwash as a preprocedural rinse in reduction of microbial count in dental aerosolTimepoint: Before and after giving interventions on same <br/ ><br>day
Secondary Outcome Measures
NameTimeMethod
There is a difference in the Zone of inhibition of Triphala, Chlorhexidine and Betadine mouthwash on Streptococcus Mutans, Lactobacillus, Prophyromonas Gingivalis, Actinomyces Viscousus, Fusobacterium Nucleatum on agar plateTimepoint: Before and after giving interventions on same <br/ ><br>day
© Copyright 2025. All Rights Reserved by MedPath